Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemodialysis Subjects With Secondary Hyperparathyroidism”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Large-scale testing (Phase 3)Ended earlyNCT04064827
What this trial is testing

Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)
AbbVie 2
Post-approval studies (Phase 4)Study completedNCT00803712
What this trial is testing

20070360 Incident Dialysis

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
Amgen 313
Testing effectiveness (Phase 2)Study completedNCT01254565
What this trial is testing

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 87
Early research (Phase 1)Study completedNCT02833857
What this trial is testing

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 11
Testing effectiveness (Phase 2)Study completedNCT00667576
What this trial is testing

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis

Who this might be right for
Chronic Kidney Disease on HemodialysisSecondary Hyperparathyroidism
Abbott 153
Large-scale testing (Phase 3)Study completedNCT02102204
What this trial is testing

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 902
Large-scale testing (Phase 3)Study completedNCT01896232
What this trial is testing

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 683
Large-scale testing (Phase 3)Study completedNCT02549404
What this trial is testing

Phase 3 Study of KHK7580

Who this might be right for
Secondary Hyperparathyroidism
Kyowa Kirin Co., Ltd. 137
Testing effectiveness (Phase 2)Study completedNCT01414114
What this trial is testing

Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT00742716
What this trial is testing

Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT06236295
What this trial is testing

Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shanghai Hengrui Pharmaceutical Co., Ltd. 303
Large-scale testing (Phase 3)Looking for participantsNCT03633708
What this trial is testing

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 56
Testing effectiveness (Phase 2)Study completedNCT00646932
What this trial is testing

Paricalcitol Injection Phase II Trial

Who this might be right for
Chronic Kidney Disease
Abbott 25
Testing effectiveness (Phase 2)Ended earlyNCT03602261
What this trial is testing

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesChronic Kidney DiseasesVitamin D Deficiency+1 more
OPKO Health, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT00990704
What this trial is testing

Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismHemodialysis
Abbott 47
Testing effectiveness (Phase 2)Study completedNCT06747247
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 98
Large-scale testing (Phase 3)Study completedNCT03822507
What this trial is testing

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

Who this might be right for
Secondary Hyperparathyroidism
Kyowa Kirin Co., Ltd. 404
Testing effectiveness (Phase 2)Looking for participantsNCT06976177
What this trial is testing

Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 310
Testing effectiveness (Phase 2)Study completedNCT06690242
What this trial is testing

MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 115
Early research (Phase 1)Study completedNCT00792857
What this trial is testing

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 24
Next Page